To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.

GLP-1 drugs like semaglutide and tirzepatide drive weight loss, but a new study finds they don't improve cardiovascular fitness and can trigger significant muscle loss. Experts urge pairing ...

WITH the price of Mounjaro set to rise and concerns about long-term affordability and access, many may be looking to turn to ...

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...

A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with ...

Tirzepatide users also reported a "greater reduction in waist circumference" than those on semaglutide. The reported side effects were very similar for the two drugs, with 44% of people ...

Fact checked by Nick Blackmer Tirzepatide and semaglutide, the ingredients in popular weight loss drugs, can both cause side effects, such as nausea, vomiting, and diarrhea.One is not safer than ...